𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Genetic heterogeneity in the precore region of hepatitis B virus in hepatitis B e antigen-negative chronic hepatitis B Patients: Spontaneous seroconversion and interferon-induced seroconversion

✍ Scribed by Tatsunobu Karasawa; Yoshio Aizawa; Mikio Zeniya; Akira Kuramoto; Gotaro Toda; Takuji Shirasawa


Publisher
John Wiley and Sons
Year
1995
Tongue
English
Weight
860 KB
Volume
45
Category
Article
ISSN
0146-6615

No coin nor oath required. For personal study only.

✦ Synopsis


To elucidate the relationship between the clinical severity of chronic liver disease and the precore mutations in hepatitis B e antigen (HBeAg)-negative hepatitis B virus (HBV) carriers, mutations were investigated in the precore region of HBV DNA in 20 chronic hepatitis B patients who seroconverted either spontaneously or after the administration of a-interferon (IFN), and 5 asyrnptomatic carriers. The precore mutation with a stop codon at nucleotide 1896 was found in all patients, irrespective of the histology and in all asymptomatic carriers. The second mutation at nucleotide 1899 was found in 40% of cases studied but always followed by the first mutation at nucleotide 1896. The mixed viral infection of precore mutant and wild-type HBV virus was found in 40% of seroconverted cases after IFN treatment and in sera of HBV carriers obtained within a year after the spontaneous seroconversion. These data suggest that the precore mutants prevail over wild-type HBV in all HBeAg-negative HBV carriers within several years after the seroconversion, but their prevalence could not confine the clinical severity of chronic liver disease.


📜 SIMILAR VOLUMES


Hepatitis B virus genotypes and spontane
✍ Jia-Horng Kao; Pei-Jer Chen; Ming-Yang Lai; Ding-Shinn Chen 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 84 KB 👁 1 views

## Abstract Hepatitis B virus (HBV) is classified into eight genotypes (A–H), and genotype C is associated with more aggressive liver disease compared to genotype B. However, the mechanisms responsible for the clinical differences remain unclear. To test whether genotype C patients had with lower r

Efficacy of lamivudine in patients with
✍ Nicolaos C. Tassopoulos; Riccardo Volpes; Giuseppe Pastore; Jenny Heathcote; Mar 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 152 KB 👁 1 views

This placebo controlled, double-blind study evaluated the efficacy and safety of lamivudine in patients with hepatitis B e antigen (HBeAg)-negative/hepatitis B virus (HBV) DNA-positive chronic hepatitis B. Patients were randomized to receive 100 mg lamivudine orally once daily for 52 weeks (n ‫؍‬ 60

Age-specific prognosis following spontan
✍ Yi-Cheng Chen; Chia-Ming Chu; Yun-Fan Liaw 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 278 KB 👁 1 views

Hepatitis B e antigen (HBeAg) seroconversion in chronic hepatitis B virus infection confers a favorable prognosis, but untoward outcomes may develop in some patients. The impact of the age of HBeAg seroconversion on prognosis is not clearly known. HBeAg-positive patients with biopsy-proven chronic h

Predictive value of precore hepatitis B
✍ Anna S. F. Lok; Ulus S. Akarca; Sheila Greene 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 642 KB

We previously reported two mutually exclusive mutations in the precore region of hepatitis B virus: MI (T-1856, proline-serine substitution at codon 15) and M 2 (A-1896, stop codon at codon 28). This study was conducted to determine if the presence of precore mutants affect spontaneous or interferon

Different hepatitis b virus genotypes ar
✍ Henry L. Y. Chan; Munira Hussain; Anna S. F. Lok 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 224 KB

Mutations in the core promoter and precore regions are frequently found in hepatitis B e antigen (HBeAg)-negative patients, but precore stop codon mutation is restricted to hepatitis B virus (HBV) genotypes that have T at nucleotide 1858. The aims of this study were to determine the role of core pro